Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
about
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical validation of the CE- ...... hort of glioblastoma patients.
@en
Clinical validation of the CE- ...... hort of glioblastoma patients.
@nl
type
label
Clinical validation of the CE- ...... hort of glioblastoma patients.
@en
Clinical validation of the CE- ...... hort of glioblastoma patients.
@nl
prefLabel
Clinical validation of the CE- ...... hort of glioblastoma patients.
@en
Clinical validation of the CE- ...... hort of glioblastoma patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinical validation of the CE- ...... ohort of glioblastoma patients
@en
P2093
Audrey Lavenu
Carole Ramirez
Catherine Carpentier
Dan Chiforeanu
Dominique Figarella-Branger
Elodie Vauleon
Emmanuèle Lechapt Zalcman
Fabienne Escande
François Ducray
Frédéric Fina
P2860
P304
P356
10.3233/CBM-170191
P577
2017-12-01T00:00:00Z